To succeed in emerging market medicine, anticipation and innovation are essential
December 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical
Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
FDA issued the fewest warnings over pharma advertising this year since 1997
December 11, 2017Sales and Marketing Amherst, FDA, advertising, cipher, orexigen, pharma
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …
Cyramza fails to improve overall survival in gastric cancer, Lilly scraps regulatory plans
December 11, 2017Research and Development, Sales and Marketing Cancer, Eli Lilly, cyramza, gastric cancer, pharma
Eli Lilly has unveiled Phase 3 results which reveal that its VEGF Receptor 2 antagonist Cyramza (ramucirumab) met its primary …
Teva job cut rumours resurface, 10,000 expected
December 11, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …
PhRMA launches lawsuit against the state of California over anti-price hike bill
December 11, 2017Sales and Marketing Drug pricing, PhRMA, california, pharma, price hikes
The state of California has become the target of legal action after the lobbying group Pharmaceutical Research and Manufacturers of …
NHS trust boss of major hospital hands in fiery resignation notice
December 11, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …
Top Ten most popular articles on Pharmafile.com this week
December 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten
Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …
Roche Tecentriq combo effective, but is it enough?
December 8, 2017Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …
Gilead makes $567m strategic acquisition for next-gen CAR-T
December 8, 2017Medical Communications, Sales and Marketing CAR-T, Cell Design Labs, Gilead, Kite, biotech, drugs, pharma, pharmaceutical
It’s only four months since Gilead completed its buy-out of Kite Pharma for $11.9 billion, but it’s already moving quickly …
Philippines ups pressure on Sanofi over dengue vaccine
December 8, 2017Medical Communications Sanofi, biotech, drugs, pharma, pharmaceutical
Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …
Sage Therapeutics stock pops on depression P2 results
December 8, 2017Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical
Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …
Fondation Ipsen announces Dr James Levine as new President
December 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …
FDA access programmes shaved up to a year off drug approval times, new study shows
December 7, 2017Research and Development, Sales and Marketing FDA, market access, pharma
A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …
Getting precision treatments over the line will be a team effort, not an individual bolt for glory
December 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer
We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …
Novartis Kisqali improves PFS in younger women
December 7, 2017Research and Development Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical
A Phase 3 trial looking at the use of Kisqali (ribociclib) to treat premenopausal or perimenopausal women with hormone-receptor positive, …
Roche’s haemophilia A drug shows meaningful bleed control in P3
December 7, 2017Research and Development Roche, haemophilia, pharma
Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …
Old anti-drinking drug shows potential as cancer treatment
December 7, 2017Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical
Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …
Clinical trial transparency research reveals progress, but more to be done
December 7, 2017Medical Communications biotech, clinical trials, drugs, pharma, pharmaceutical
Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …
Galectin Therapeutics’ share value plummets by half after NASH drug failure
December 6, 2017Research and Development Galectin Therapeutics, nash, pharma, trial failure
Galectin Therapeutics has seen its share value almost halve after its revealed that GR-MD-02, its experimental treatment for non-alcoholic steatohepatitis …
Two big pharma companies accused of false marketing
December 6, 2017Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
